Imagion Biosystems Limited (IBX.AX)
AUD 0.02
(5.56%)
AUD 0.02
(5.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.03 Million AUD | 31.14% |
| 2022 | 4.6 Million AUD | 9905.58% |
| 2021 | 46.01 Thousand AUD | -93.04% |
| 2020 | 660.97 Thousand AUD | -24.61% |
| 2019 | 876.77 Thousand AUD | 1508.3% |
| 2018 | 54.51 Thousand AUD | -31.87% |
| 2017 | 80.01 Thousand AUD | -99.43% |
| 2016 | 13.92 Million AUD | 46.7% |
| 2015 | 9.49 Million AUD | 126.63% |
| 2014 | 4.18 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.16 Million AUD | 0.66% |
| 2024 Q1 | 3.16 Million AUD | -47.51% |
| 2023 Q2 | 5.81 Million AUD | 27.34% |
| 2023 Q1 | 4.56 Million AUD | -0.77% |
| 2023 Q4 | 6.03 Million AUD | 22.17% |
| 2023 Q3 | 4.94 Million AUD | -15.04% |
| 2023 FY | 6.03 Million AUD | 31.14% |
| 2022 Q4 | 4.6 Million AUD | 29.22% |
| 2022 Q2 | 5.12 Million AUD | 28.37% |
| 2022 FY | 4.6 Million AUD | 9905.58% |
| 2022 Q3 | 3.56 Million AUD | -30.45% |
| 2022 Q1 | 3.99 Million AUD | 8572.52% |
| 2021 Q1 | 37.91 Thousand AUD | -94.26% |
| 2021 FY | 46.01 Thousand AUD | -93.04% |
| 2021 Q2 | 195.42 Thousand AUD | 415.38% |
| 2021 Q4 | 46.01 Thousand AUD | 49.04% |
| 2021 Q3 | 30.87 Thousand AUD | -84.2% |
| 2020 Q4 | 660.97 Thousand AUD | 118.33% |
| 2020 Q1 | 451.48 Thousand AUD | -48.51% |
| 2020 Q2 | 744.61 Thousand AUD | 64.93% |
| 2020 FY | 660.97 Thousand AUD | -24.61% |
| 2020 Q3 | 302.74 Thousand AUD | -59.34% |
| 2019 Q3 | 615.01 Thousand AUD | 1562.62% |
| 2019 Q1 | 18.55 Thousand AUD | -65.97% |
| 2019 FY | 876.77 Thousand AUD | 1508.3% |
| 2019 Q2 | 36.99 Thousand AUD | 99.39% |
| 2019 Q4 | 876.77 Thousand AUD | 42.56% |
| 2018 Q3 | 18.43 Thousand AUD | -64.59% |
| 2018 Q1 | 52.05 Thousand AUD | -34.94% |
| 2018 FY | 54.51 Thousand AUD | -31.87% |
| 2018 Q4 | 54.51 Thousand AUD | 195.74% |
| 2018 Q2 | 52.05 Thousand AUD | 0.0% |
| 2017 Q1 | 66.63 Thousand AUD | 0.0% |
| 2017 Q4 | 80.01 Thousand AUD | 62.2% |
| 2017 Q3 | 49.32 Thousand AUD | -25.97% |
| 2017 Q2 | 66.63 Thousand AUD | 0.0% |
| 2017 FY | 80.01 Thousand AUD | -99.43% |
| 2016 FY | 13.92 Million AUD | 46.7% |
| 2015 FY | 9.49 Million AUD | 126.63% |
| 2014 FY | 4.18 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 308.89 Million AUD | 98.045% |
| BCAL Diagnostics Limited | 641.34 Thousand AUD | -841.52% |
| Genetic Signatures Limited | 1.22 Million AUD | -394.541% |
| Genetic Technologies Limited | 643.54 Thousand AUD | -838.293% |
| Healius Limited | 1.59 Billion AUD | 99.622% |
| Integral Diagnostics Limited | 357.79 Million AUD | 98.312% |
| INOVIQ Ltd | 535.05 Thousand AUD | -1028.538% |
| Microba Life Sciences Limited | 395.38 Thousand AUD | -1427.199% |
| Monash IVF Group Limited | 59.56 Million AUD | 89.863% |
| Rhythm Biosciences Limited | 163.82 Thousand AUD | -3585.919% |
| Sonic Healthcare Limited | 4.51 Billion AUD | 99.866% |